Roche suffers setback as court allows generic version of its rare disease drug to be sold in India In closely watched case, court says generics company can proceed with plan for lower-cost therapy for spinal muscular atrophy

https://www.statnews.com/pharmalot/2025/10/10/roche-india-patents-medicines-rare-disease/